Prosiding P 362.1 WOR w Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Foundations of cost-effectiveness analysis for health and medical practices, Milton C. Weinsrein; StasonWilliam B.; 2. Cost-effectiveness analysis: an introductory guide for clinicians, Marcones, George A; 3. Developmentof WHO guidelines on generalized cost-effectiveness analysis, Murray, Christopher J.L; (et al); 4. Cost analysis in primary health care: a training manual for programme managers, Andrew Creese; 5. Public hospitals in developing countries: resource use, cost, financing, Howard Barnum; 6. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 7. National price levels and the prices of tradables and nontradables, Irving B. Kravis; 8. For here or to go ? Purchasing power parity and the big mac, Michael R. Pakko; 9. Cost-analysis: issues and methodologies, Anandarup Ray; 10. THe Penn World Table (PWT) estimates of purchasing power parities and consumption, invesment, and governt price parities for non-benchmark countries (with special reference to PWT 5.6), Alan Heston; 11. The real and nominal? making inflationary adjusments to cost and other economic data, Lilani Kumaranayake; 12. Discounting human lives, Maureen L Cropper; 13. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 14. Time preference, J. Lipscomp; 15. Time preference in medical making and cost-effectiveness analysis , Donald A Redelmier; 15. Discounting costs and effects: a reconsideration, Ben A. Van Hout; 16. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, FRank A. Sloan; 17. Standardizing methodologies for economic evaluation in health care: practice, problems, and potential, Michael Drummond; 18. How much does excess inpatient capacity really cost ?, Parves R. Sopariwala; 19. Applying ABC to healthcare: as rising costs impact managed care, a successful manufacturing costing method is being applied to help managers make decisions on capitation contract bidding, cost containment, and organizational structure, Twothy D. West; 20.. IMCI multi-country evaluation form 5 A: health facility costs questionnaire; 21. The usefulness of rations for allocation decisions: the case of stroke, A. Ament; 22. A review of the use of health status measures in economic evaluation, J Brazier; 23. Preference-based measures in economic evaluation in health care, Peter J. Neumann; 24. Multi-aatribute preference functions: health utilities index, George W. Torrance; 25. Utilities and quality-adjusted life years, George W. Torrance; 26. Disability-adjusted life years: a critical review, Sudhir anand; 27. Understanding DALYs, Christopher J.L. Murray; 28. QALYs, HYEs and individualpreferences - a graphical illustration, Magnus Johannesson; 29. What randomized trials and systematic reviews can offer decision makers, Douglas G. Altman; 30. Evaluation of health interventions at area and organisation level, Obioha C Ukoumunne; 31. Interpreting the evidence: choosing between randomised and non-randomised studis, Martin McKee; 32. An evidence based approach to individualising treatment, Paul P. Glasziou; 33. Efficacy and effectiveness issues in the NIDA cooperative agreement: interventions for out-of-teatment drug-users; 34. The practice of antenatal care: comparing four study sites in different parts of the world participating in the WHO antenatal care rondomized controlled trial, Gilda Piaggio; 35. Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease, Thommas A. Pearson) WHO Health Policy-Workshop Health Expendditure-Proceedings Cost Benefit Analysis-Proceedings Cost Effectiveness-Proceedings Geneva: WHO, 2000 https://lib.fkm.ui.ac.id:443/detail?id=45185